A detailed history of Trust Point Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Trust Point Inc. holds 11,343 shares of GKOS stock, worth $1.49 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
11,343
Previous 10,957 3.52%
Holding current value
$1.49 Million
Previous $1.3 Billion 13.96%
% of portfolio
0.11%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$113.62 - $135.39 $43,857 - $52,260
386 Added 3.52%
11,343 $1.48 Billion
Q2 2024

Jul 24, 2024

BUY
$89.48 - $118.35 $18,611 - $24,616
208 Added 1.94%
10,957 $1.3 Billion
Q1 2024

Apr 19, 2024

BUY
$76.4 - $96.33 $287,340 - $362,297
3,761 Added 53.82%
10,749 $1.01 Billion
Q4 2023

Jan 23, 2024

BUY
$59.53 - $85.11 $415,995 - $594,748
6,988 New
6,988 $555 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.27B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Trust Point Inc. Portfolio

Follow Trust Point Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Point Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trust Point Inc. with notifications on news.